Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares Issued
Ratios

Legend Biotech (LEGN) Leases (2019 - 2025)

Legend Biotech filings provide 7 years of Leases readings, the most recent being $285.2 million for Q4 2025.

  • On a quarterly basis, Leases rose 179.88% to $285.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $285.2 million, a 179.88% increase, with the full-year FY2025 number at $285.2 million, up 179.88% from a year prior.
  • Leases hit $285.2 million in Q4 2025 for Legend Biotech, up from $142.3 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $285.2 million in Q4 2025 to a low of $7547.0 in Q1 2021.
  • Median Leases over the past 5 years was $80.3 million (2023), compared with a mean of $84.5 million.
  • Biggest five-year swings in Leases: soared 526877.61% in 2022 and later dropped 0.35% in 2024.
  • Legend Biotech's Leases stood at $38.3 million in 2021, then surged by 45.21% to $55.6 million in 2022, then soared by 44.81% to $80.5 million in 2023, then increased by 26.58% to $101.9 million in 2024, then soared by 179.88% to $285.2 million in 2025.
  • The last three reported values for Leases were $285.2 million (Q4 2025), $142.3 million (Q3 2025), and $127.2 million (Q2 2025) per Business Quant data.